News & Events

We are thrilled to announce the first launch of SIROS™-Sirtex’s innovative New Dose Administration System in Oman. This milestone was achieved in collaboration with our esteemed client, Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC-UMC) in Muscat, under the visionary leadership of Dr. Rashid Al Sukaiti. Notably, SQCCCRC has become the first public hospital in the GCC region to implement this cutting-edge system for the delivery of Y-90 therapy, marking a significant advancement in cancer care.

The SIROS™ Delivery System offers an intuitive, visual, and adaptable solution for physicians to administer SIR-Spheres to liver cancer patients. Its easy-to-use design along with the controlled administration provides the physicians confidence in the Y-90 delivery.

We would like to extend our heartfelt gratitude to Dr. Rashid Al Sukaiti, Dr. Khulood Al Riyami and their dedicated teams, our Sales team and our partner Sirtex for their tireless efforts in making this project a reality. Together, we are committed to advancing healthcare technology for a brighter future!

Key features of SIROS system include:

• Visual: Visually controlled administration enables precision.
• Intuitive: Intuitive design for easy set-up, fluid administration and quick disposal.
• Versatility: Enhanced control allows for more options to tailor sphere delivery.

At Zahrawi Group, we believe in harnessing advanced technology to advance the field of oncology and provide the best possible solutions to our healthcare partners. This launch represents our commitment to supporting patients and practitioners in the journey towards better health.

Our commitment to improving patient care drives us to continually push the boundaries of medical technology. We believe this new system will revolutionize the way liver radioembolization is performed, ultimately leading to better patient outcomes.